Cargando…

Mitochondrial D310 mutations in the early development of breast cancer

BACKGROUND: The role of mitochondrial DNA (mtDNA) mutations in the development of breast cancer is largely unknown. In this study, we investigated the frequency and pattern of mutations in the D310 region, the most commonly mutated region in mtDNA, in a series of breast lesions. METHODS: Using capil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, C, Tran-Thanh, D, Ma, C, May, K, Jung, J, Vecchiarelli, J, Done, S J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341870/ https://www.ncbi.nlm.nih.gov/pubmed/22472881 http://dx.doi.org/10.1038/bjc.2012.74

Ejemplares similares

Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma
por: Lièvre, A, et al.
Publicado: (2006)

Assessment of DNA methylation status in early stages of breast cancer development
por: van Hoesel, A Q, et al.
Publicado: (2013)

Mitochondrial D-loop mutations and deletion profiles of cancerous and noncancerous liver tissue in hepatitis B virus-infected liver
por: Wheelhouse, N M, et al.
Publicado: (2005)

Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility
por: Challen, C, et al.
Publicado: (2011)

Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolism
por: Meierhofer, D, et al.
Publicado: (2006)

Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations
por: Secq, V, et al.
Publicado: (2014)

Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis
por: Nishikawa, M, et al.
Publicado: (2005)

Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
por: Jerevall, P-L, et al.
Publicado: (2011)

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy
por: Manton, D J, et al.
Publicado: (2006)

Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancer
por: Kazdal, Daniel, et al.
Publicado: (2017)

Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction
por: Baneshi, M R, et al.
Publicado: (2010)

Mitochondrial D310 mutation as clonal marker for solid tumors
por: Geurts-Giele, Willemina R. R., et al.
Publicado: (2015)

Evaluation of models to predict BRCA germline mutations
por: Kang, H H, et al.
Publicado: (2006)

Human papilloma virus is associated with breast cancer
por: Heng, B, et al.
Publicado: (2009)

A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer
por: Molloy, T J, et al.
Publicado: (2011)

DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers
por: Kotsopoulos, J, et al.
Publicado: (2007)

Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid
por: Máximo, V, et al.
Publicado: (2005)

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
por: Engels, C C, et al.
Publicado: (2014)

Koilocytes indicate a role for human papilloma virus in breast cancer
por: Lawson, J S, et al.
Publicado: (2009)

BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome
por: Saridaki, Z, et al.
Publicado: (2010)

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples
por: Kazarian, Anna, et al.
Publicado: (2017)

The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer
por: Mohammed, Z MA, et al.
Publicado: (2012)

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer
por: Burford, B, et al.
Publicado: (2013)

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
por: Millar, E K A, et al.
Publicado: (2011)

Microsatellite mutations in buccal cells are associated with aging and head and neck carcinoma
por: Slebos, R J C, et al.
Publicado: (2008)

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer
por: Zhu, C, et al.
Publicado: (2014)

Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification
por: Betof, A S, et al.
Publicado: (2012)

Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma
por: Hugdahl, Emilia, et al.
Publicado: (2018)

A novel AKT3 mutation in melanoma tumours and cell lines
por: Davies, M A, et al.
Publicado: (2008)

Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis
por: Mohammed, R A A, et al.
Publicado: (2007)

Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma
por: Colley, H E, et al.
Publicado: (2011)

PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients
por: Harwood, C A, et al.
Publicado: (2008)

Tumour morphology predicts PALB2 germline mutation status
por: Teo, Z L, et al.
Publicado: (2013)

K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene
por: Hachisuga, T, et al.
Publicado: (2005)

Overexpressed vs mutated Kras in murine fibroblasts: a molecular phenotyping study
por: Horsch, M, et al.
Publicado: (2009)

Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias
por: Kim, M S, et al.
Publicado: (2008)

Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival
por: Dawson, S J, et al.
Publicado: (2009)

Comparison of Visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer
por: Mohammed, Z M A, et al.
Publicado: (2012)

KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis
por: Deschoolmeester, V, et al.
Publicado: (2010)

Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease
por: Bluff, J E, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2amfjbda6r2s0109ier2rntp99